SingHealth Investigational Medicine Unit   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Singapore Singapore (2000)

Organization Overview

First Clinical Trial
2017
NCT03225456
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

KK Hospital, SingHealth Duke NUS | SingHealth Investigational Medicine Unit | SingHealth Investigational Medicine Unit (IMU) | SingHealth Regional Health System | Translational Immunology Institute